487-70-7Relevant articles and documents
Alternative routes to the acylphloroglucinol rhodomyrtone
Morkunas, Marius,Maier, Martin E.
, p. 9662 - 9666 (2015)
Two novel routes to the acylphloroglucinol rhodomyrtone (1) which has antibiotic properties are presented. In the first route an ortho-quinone methide, generated from dioxaborinine 23, is reacted with syncarpic acid (10) leading to xanthenedione 25. Cleavage of the methyl ether functions led to the known rhodomyrtone precursor 16. In the second route the bis-ester derivative 28 of trihydroxybenzaldehyde 26 is condensed with syncarpic acid (10) to give tricyclic hemiacetal 29. Acetalization and cuprate addition to the enone function led to bis-ester 32 which gave rhodomyrtone (1) by TiCl4-induced regioselective Fries rearrangement.
On the thermal degradation of anthocyanidins: Cyanidin
Cabrita, Luis,Petrov, Vesselin,Pina, Fernando
, p. 18939 - 18944 (2014)
Cyanidin was studied by direct pH jumps (from equilibrated solutions at very low pH values to higher pH values) and reverse pH jumps (from equilibrated or not equilibrated solutions at higher pH values to very low ones). The kinetic steps of the direct and reverse pH jumps were followed by stopped flow, absorption spectroscopy and HPLC, at different timescales. The pH dependent rate constant of the slower kinetic process to reach the equilibrium follows a bell shaped curve as described for many synthetic flavylium compounds. Unlike anthocyanins, it was proved that there is no pH dependent reversibility in the system, since the chalcone suffers an irreversible degradation process. The mathematical expression to describe the bell shaped behaviour was deduced. These results contribute to explain why in plants glycosylation is crucial for the stabilization of the anthocyanins.
Anti-oxidant activity of flavonols: Reactivity with potassium superoxide in the heterogeneous phase
Tournaire,Hocquaux,Beck,Oliveros,Maurette
, p. 9303 - 9314 (1994)
Oxidation of flavonols by potassium superoxide (KO2) in heterogeneous aprotic media yields acids and aldehydes by opening of ring C, if the latter contains an ethylenic double bond substituted by an OH group. A mechanism is proposed for this reaction. Other flavonoids like flavones, flavans and flavanones induce only the disproportionation of superoxide anion, without undergoing further oxidation; these flavonoids are therefore anti-oxidants of particular interest.
Synthetic method of pilosin B and intermediate pseudomonophenols thereof
-
Paragraph 0040; 0066, (2021/11/26)
The invention discloses a method for synthesizing pilosin B and intermediate pseudomonophenols thereof. The synthesis method of the pseudo-sheep equol comprises the step E. Step F and Step g. The synthetic method of the pilosin B provided by the invention is prepared by the following steps H, step J, preparation of the pseudomonophenols synthesized by the above method, and preparation of the pseudomonophenols synthesized by the method in step I. In step E, the novel amino protecting reagent with good reaction with the phenolic hydroxyl group is used as a protecting reagent, the phenol hydroxyl group of each intermediate in the intermediate molecule fragment a synthesis process is selectively protected, the reagent types are reduced and the use of toxic reagents such as benzyl chloride and the like is avoided.
Discovery of Anti-TNBC Agents Targeting PTP1B: Total Synthesis, Structure-Activity Relationship, in Vitro and in Vivo Investigations of Jamunones
Hu, Caijuan,Li, Guoxun,Mu, Yu,Wu, Wenxi,Cao, Bixuan,Wang, Zixuan,Yu, Hainan,Guan, Peipei,Han, Li,Li, Liya,Huang, Xueshi
supporting information, p. 6008 - 6020 (2021/05/06)
Twenty-three natural jamunone analogues along with a series of jamunone-based derivatives were synthesized and evaluated for their inhibitory effects against breast cancer (BC) MDA-MB-231 and MCF-7 cells. The preliminary structure-activity relationship revealed that the length of aliphatic side chain and free phenolic hydroxyl group at the scaffold played a vital role in anti-BC activities and the methyl group on chromanone affected the selectivity of molecules against MDA-MB-231 and MCF-7 cells. Among them, jamunone M (JM) was screened as the most effective anti-triple-negative breast cancer (anti-TNBC) candidate with a high selectivity against BC cells over normal human cells. Mechanistic investigations indicated that JM could induce mitochondria-mediated apoptosis and cause G0/G1 phase arrest in BC cells. Furthermore, JM significantly restrained tumor growth in MDA-MB-231 xenograft mice without apparent toxicity. Interestingly, JM could downregulate phosphatidylinositide 3-kinase (PI3K)/Akt pathway by suppressing protein-tyrosine phosphatase 1B (PTP1B) expression. These findings revealed the potential of JM as an appealing therapeutic drug candidate for TNBC.
Biomimetic total syntheses of baefrutones A-D, baeckenon B, and frutescones A, D-F
Dong, Ying-Ying,Hou, Ji-Qin,Peng, Qiu-Shi,Wang, Hao,Yu, Jiang-Hong,Zhang, Bao-Bao,Zhao, Heng
supporting information, p. 1135 - 1139 (2020/02/22)
Biomimetic total syntheses of baefrutones A-D (1-4), baeckenon B (5), and frutescones A, D-F (6-9), isolated from the leaves of Baeckea frutescens, were achieved in 9, 8, and 5 steps, respectively, in moderate to good yields (72-83%). The synthetic routes feature the Michael addition, oxidative [4 + 2] cycloaddition, and water-promoted Diels-Alder click reactions as the key steps. This study helped gain thorough mechanistic insights into the biosynthetic origins and provided a facile approach for the construction of a library of natural tasmanone-based meroterpenoid analogues. Moreover, compounds 1-9 show potent inhibitory effects against S. paratyphi and/or C. albicans with MIC values of 3.125-25 μg mL-1, and they could be promising lead molecules for the design of new antibiotic agents.
Synthesis and biological evaluation of BMS-986120 and its deuterated derivatives as PAR4 antagonists
Chen, Panpan,Ren, Shenhong,Song, Hangyu,Chen, Cai,Chen, Fangjun,Xu, Qinglong,Kong, Yi,Sun, Hongbin
, p. 116 - 124 (2018/11/30)
BMS-986120 is a PAR4 antagonist that is being investigated as an antiplatelet agent in phase I clinical trial. An improved synthesis of BMS-986120 has been developed. Based on the novel synthetic approach to BMS-986120, a series of deuterated derivatives of BMS-986120 have been synthesized and biologically evaluated to search for more potent antiplatelet agents. The in vitro antiplatelet assay by turbidimetry demonstrated that PC-2 and PC-6 had IC50 values of 6.30 nM and 6.97 nM, respectively, versus BMS-986120 with an IC50 of 7.80 nM. The result of in vitro metabolic stability study showed that all of the deuterated compounds had similar half-life (T1/2) and intrinsic clearance (Clint) in comparison with BMS-986120. Further probing the metabolic profile of BMS-986120 is worth being conducted.
Novel diphenylmethyl compounds having mycobacterium tuberculosis inhibitory activity
-
Paragraph 0270-0273, (2019/02/13)
The invention relates to novel diphenylmethyl derivatives having mycobacterium tuberculosis inhibitory activity and a preparation method thereof and particularly relates novel diphenylmethyl derivatives having activity for inhibiting replicative and non-replicating mycobacterium tuberculosis and a preparation method thereof. In particular, the invention relates to compounds shown in the formula (I) or all possible isomers, prodrugs, pharmaceutically acceptable salts, solvates or hydrates thereof, wherein the variables are as described in the specification. The invention also relates to the preparation method of the compounds and their pharmaceutical compositions and a use of the compounds in preparation of drugs for treating mycobacterium tuberculosis infection-caused diseases.
Derivatives of Natural Product Agrimophol as Disruptors of Intrabacterial pH Homeostasis in Mycobacterium tuberculosis
Wu, Jie,Mu, Ran,Sun, Mingna,Zhao, Nan,Pan, Miaomiao,Li, Hongshuang,Dong, Yi,Sun, Zhaogang,Bai, Jie,Hu, Minwan,Nathan, Carl F.,Javid, Babak,Liu, Gang
, p. 1087 - 1104 (2019/05/22)
This article reports the rational medicinal chemistry of a natural product, agrimophol (1), as a new disruptor of intrabacterial pH (pHIB) homeostasis in Mycobacterium tuberculosis (Mtb). Through the systematic investigation of the structure-activity relationship of 1, scaffold-hopping of the diphenylmethane scaffold, pharmacophore displacement strategies, and studies of the structure-metabolism relationship, a new derivative 5a was achieved. Compound 5a showed 100-fold increased potency in the ability to reduce pHIB to pH 6.0 and similarly improved mycobactericidal activity compared with 1 against both Mycobacterium bovis-BCG and Mtb. Compound 5a possessed improved metabolic stability in human liver microsomes and hepatocytes, lower cytotoxicity, higher selectivity index, and similar pKa value to natural 1. This study introduces a novel scaffold to an old drug, resulting in improved mycobactericidal activity through decreasing pHIB, and may contribute to the critical search for new agents to overcome drug resistance and persistence in the treatment of tuberculosis.
Deuterated imidazole and thiadiazole derivatives and their medical use (by machine translation)
-
Paragraph 0093-0096, (2019/10/07)
The invention of formula (I) indicated by the deuterated imidazole and thiadiazole derivative, or its pharmaceutically acceptable salt or esters or solvates. The compounds of this invention can be used for preparing the prevention or treatment of the thromboembolism drug. (by machine translation)
